Research and Markets research forecasts that the global clinical trial service market will likely reach more than $64 billion by 2020, up from $38.4 billion at present, representing a CAGR of 9% between 2015 and 2020. By 2020 the average clinical…
The top 10 drug launches of 2017
After an unusually slow year for new drug approvals—the FDA greenlighted just 22 meds in 2016—it remains to be seen whether drugmakers can do much better in 2017. One thing’s for sure, though: No matter what total the industry tallies…
India has come up with Medical Devices Rules, 2017
CDSCO has published the Medical Devices Rules 2017. This Rule has been published in the Gazette of India Extraordinary on 31 Jan 2017. The Rules are very explicitly explains the requirements from various stake holders and balanced in managing…
New FDA Drug Approvals: Breaking Down the Numbers
If a decline in US Food and Drug Administration (FDA) approvals of new pharmaceuticals is a bad sign for the industry, then 2016 was the worst year since 2010. And with only 18 FDA decisions on new drugs expected in…
Report: Global drug market will hit $1.5T in 2021
Total spending on medicines is forecast to reach $1.5 trillion by 2021, up 33% from 2016 levels, even as annual growth moderates from the record pace set in 2014 and 2015, according to new research released by the QuintilesIMS Institute. While…
Minutes of 74th Meeting of Drugs Technical Advisory Board
CDSCO has shared the minutes of 74th meeting of Drugs Technical Advisory Board Held on 15th nov 2016 at DGHS, Norman Bhawan, New-Delhi Important point which was discussed in the meeting pertaining to Clinical Trials are it was recommended that…
Pharma research approval system to be put on fast track
NEW DELHI: The BJP-led NDA government will set up a single window approval system that will clear in 30 days what four different committees took 3-4 years in a major boost to innovation in medical research and will help improve…
CDSCO has come up with the list of NABL accredited NABL certified Laboratory
CDSCO has come up with the list of NABL accredited laboratory in India which is good for the Pharma companies and CRO who are conducting clinical studies in India. This step of CDSCO has been welcomed by Pharma and CRO…
Govt Consults Top Foreign Regulators to Rewrite Drug Laws
Finally junking the 75-year-old Drug and Cosmetics Act, the health ministry is consulting top drug regulation bodies worldwide in order to write a new laws for drugs. Until last year, the government is trying to tweak its archaic Drugs and…
GOI forwarded Proposal to waive Phase III clinical studies
The country’s drug controller is planning to waive local clinical trial of drugs meant to treat certain type of cancer, AIDS, hepatitis and rare blood disorders if the drugs are cleared in “well-regulated” countries like the US, Australia, Canada, Europe…
